Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN
McCourt Marion sold 566 Regeneron Pharmaceuticals, Inc. shares (Form 4)
Traded Nov 16, 2026 · Filed Nov 18, 2026
On Nov 16, 2026, McCourt Marion (EVP Commercial) sold 566 Regeneron Pharmaceuticals, Inc. shares at an average US$960.25 for US$544K under a trading plan, leaving 10,305 shares. Filed Nov 18, 2026 (Form 4).
- Sold
- 566 shares
- Price
- US$960.25 average (US$952.79 to US$971.93)
- Value
- US$544K
- Holding after
- 10,305 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP Commercial
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Stock | Sale | 44 | US$952.79 | 10,827 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 59 | US$954.46 | 10,768 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 30 | US$955.51 | 10,738 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 22 | US$956.01 | 10,716 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 44 | US$958.47 | 10,672 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 66 | US$959.46 | 10,606 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 49 | US$960.31 | 10,557 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 59 | US$961.36 | 10,498 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 41 | US$962.44 | 10,457 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 42 | US$963.70 | 10,415 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 21 | US$964.69 | 10,394 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 63 | US$965.62 | 10,331 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 26 | US$971.93 | 10,305 | Direct |
Source
Download original · View original at SEC
Related
- Regeneron Pharmaceuticals, Inc.
- McCourt Marion
- Regeneron Pharmaceuticals, Inc. shareholders
- Form 4 · McCourt Marion · Nov 3, 2026
- Form 4 · McCourt Marion · Sep 3, 2026
- Form 4 · Murphy Andrew J · Nov 18, 2026
- Form 4 · Sing George L · Nov 18, 2026
- Form 4 · Pitofsky Jason · Nov 6, 2026
- Schedule 13G · Vanguard Capital Management LLC · Apr 30, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026